Masimo (MASI) Capital Expenditures Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.08% |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn | -20.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -20.32% |
| Jan 3, 2026 | -24.96% |
| Sep 27, 2025 | -0.56% |
| Jun 28, 2025 | -26.32% |
| Mar 29, 2025 | -49.76% |
| Dec 28, 2024 | 29.66% |
| Mar 30, 2024 | -11.84% |
| Sep 30, 2023 | 13.21% |
| Jul 1, 2023 | -5.85% |
| Apr 1, 2023 | -38.76% |
| Dec 31, 2022 | 10.92% |
| Oct 1, 2022 | -11.79% |
| Jul 2, 2022 | -38.26% |
| Apr 2, 2022 | 43.32% |
| Jan 1, 2022 | -109.16% |
| Apr 3, 2021 | 32.96% |
| Sep 26, 2020 | -33.16% |
| Jun 27, 2020 | 51.29% |
| Mar 28, 2020 | 103.45% |
| Dec 28, 2019 | 27.00% |
| Sep 28, 2019 | 43.42% |
| Jun 29, 2019 | 95.66% |
| Mar 30, 2019 | 9.21% |
| Dec 29, 2018 | 31.87% |
| Mar 31, 2018 | -39.63% |
| Sep 30, 2017 | 83.38% |
| Jul 1, 2017 | -58.84% |
| Apr 1, 2017 | 13.00% |
| Dec 31, 2016 | 33.64% |
| Oct 1, 2016 | -0.12% |
| Jul 2, 2016 | 36.97% |
| Apr 2, 2016 | 42.72% |
| Jan 2, 2016 | -100.69% |
| Apr 4, 2015 | 108.01% |
| Sep 27, 2014 | 50.85% |
| Jun 28, 2014 | 255.43% |
| Mar 29, 2014 | 55.62% |
| Dec 28, 2013 | -27.73% |
| Mar 30, 2013 | -0.82% |
| Sep 29, 2012 | 48.77% |